Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.65 Million shares of ROIV, which is worth approximately $22.3 Million. The most recent transaction as insider was on Jul 20, 2023, when has been sold 159,387 shares (Common Shares) at a price of $11.31 per share, resulting in proceeds of $1,802,666. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M
13.09% 3M change
158.63% 12M change
Total Value Held $22.3 Million

Eric Venker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 20 2023
SELL
Open market or private sale
$1,802,666 $11.31 p/Share
159,387 Reduced 19.83%
644,215 Common Shares
Jul 20 2023
BUY
Exercise of conversion of derivative security
$613,639 $3.85 p/Share
159,387 Added 16.55%
803,602 Common Shares
Jun 22 2023
SELL
Other acquisition or disposition
$158,978 $10.01 p/Share
15,882 Reduced 2.41%
644,215 Common Shares
Jun 09 2023
SELL
Open market or private sale
$2,966,895 $9.91 p/Share
299,384 Reduced 31.2%
660,097 Common Shares
Jun 09 2023
BUY
Exercise of conversion of derivative security
$1,152,628 $3.85 p/Share
299,384 Added 23.78%
959,481 Common Shares
Jun 07 2023
SELL
Open market or private sale
$1,979 $9.85 p/Share
201 Reduced 0.03%
660,097 Common Shares
Jun 07 2023
BUY
Exercise of conversion of derivative security
$773 $3.85 p/Share
201 Added 0.03%
660,298 Common Shares
May 23 2023
SELL
Other acquisition or disposition
$150,128 $9.58 p/Share
15,671 Reduced 2.32%
660,097 Common Shares
May 23 2023
SELL
Open market or private sale
$4,087 $9.85 p/Share
415 Reduced 0.06%
675,768 Common Shares
May 23 2023
BUY
Exercise of conversion of derivative security
$1,597 $3.85 p/Share
415 Added 0.06%
676,183 Common Shares
May 09 2023
SELL
Open market or private sale
$2,203,422 $9.23 p/Share
238,724 Reduced 26.1%
675,768 Common Shares
May 09 2023
BUY
Exercise of conversion of derivative security
$919,087 $3.85 p/Share
238,724 Added 20.7%
914,492 Common Shares
May 08 2023
SELL
Open market or private sale
$546,569 $8.93 p/Share
61,206 Reduced 8.31%
675,768 Common Shares
May 08 2023
BUY
Exercise of conversion of derivative security
$235,643 $3.85 p/Share
61,206 Added 7.67%
736,974 Common Shares
May 04 2023
SELL
Open market or private sale
$737,355 $8.3 p/Share
88,838 Reduced 11.62%
675,768 Common Shares
May 04 2023
BUY
Exercise of conversion of derivative security
$342,026 $3.85 p/Share
88,838 Added 10.41%
764,606 Common Shares
May 03 2023
SELL
Open market or private sale
$997,584 $8.4 p/Share
118,760 Reduced 14.95%
675,768 Common Shares
May 03 2023
BUY
Exercise of conversion of derivative security
$457,226 $3.85 p/Share
118,760 Added 13.0%
794,528 Common Shares
May 02 2023
SELL
Open market or private sale
$904,223 $8.29 p/Share
109,074 Reduced 13.9%
675,768 Common Shares
May 02 2023
BUY
Exercise of conversion of derivative security
$419,934 $3.85 p/Share
109,074 Added 12.2%
784,842 Common Shares
May 01 2023
SELL
Open market or private sale
$525,321 $8.59 p/Share
61,155 Reduced 8.3%
675,768 Common Shares
May 01 2023
BUY
Exercise of conversion of derivative security
$235,446 $3.85 p/Share
61,155 Added 7.66%
736,923 Common Shares
Apr 28 2023
SELL
Open market or private sale
$642,220 $8.47 p/Share
75,823 Reduced 10.09%
675,768 Common Shares
Apr 28 2023
BUY
Exercise of conversion of derivative security
$291,918 $3.85 p/Share
75,823 Added 9.16%
751,591 Common Shares
Apr 27 2023
SELL
Open market or private sale
$625,604 $8.51 p/Share
73,514 Reduced 9.81%
675,768 Common Shares

Also insider at

IMVT
Immunovant, Inc. Healthcare
EV

Eric Venker

President & Immunovant CEO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV